Amwell targets 60% subscription revenue mix for 2025, driven by DHA and cost reductions
Q4 2024 Management View CEO Ido Schoenberg highlighted the completion of transformative efforts in 2024, including a strategic focus on the company's core mission and the refinement of its unified ...